Form D · Pharmaceuticals

AMPLA PHARMACEUTICALS INC

Boston, MA · CIK 0001381508

Offering snapshot reported Feb 28, 2013 · SEC filing

Reported sold: $3.65M
Investors reported: 6
Minimum accepted: $0
First sale: Jan 28, 2010

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$1,467,898 → $3,650,000

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Feb 28, 2013	Amendment	$3,650,000	$2,182,102vs Apr 29, 2011	6	SEC filing
Apr 29, 2011	Amendment	$1,467,898	$1,172,627vs Feb 10, 2010	6	SEC filing
Feb 10, 2010	Initial	$295,271	No comparison	6	SEC filing
Nov 3, 2006	Paper	Not reported	No comparison	Not reported	SEC filing

Offering details

Securities: Equity
Exemptions: 06
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-96858

Source: Form D, filed Feb 28, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Eric Bednarski	Director
Charles Cohen	Director, Executive
Jason Fisherman	Director
James Hauske	Director, Executive
Jerry Wisler	Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:

C/O Advent Healthcare Ventures 184 High Street, 4 Th Floor
Boston, MA, 02110